Nephrology Videos
Advertisement
Joel Topf spoke with Connie Rhee at SCM25 about her study on cognitive function with dialysis vs conservative CKD management.
Joel Topf spoke with Bradley Marder of Amgen about gout studies at the NKF Spring Clinical Meetings 2025.
Joel Topf spoke to Excellence in Transplantation Award winner Jayme Locke at the National Kidney Foundation SCM25.
Dr. Thomas Pham spoke to us about kidney donation during National Donate Life Month.
Suphamai Bunnapradist discussed the phase 3 TRANSCEND study of felzartamab to treat late AMR after kidney transplantation.
Faith Lynch, president-elect of ANNA, discussed her upcoming term and challenges faced by nephrology nurses.
Babak Orandi spoke with us about a study showing that GLP-1 drugs have benefits for kidney transplant recipients with T2D.
Eledon Pharmaceuticals CEO David-Alexandre Gros, MD, spoke about the role of CD40L blocker tegoprubart in transplantation.
Nephrology Times spoke with Amber Sanchez, MD, about the use of apheresis in nephrology.
Wei Ling Lau, MD, discussed the potential impact of AccurKardia's AK+ Guard hyperkalemia detection software.
Len Usvyat spoke with Nephrology Times about the use of artificial intelligence in kidney care.
Vlado Perkovic spoke about findings from the FLOW, APPLAUSE-IgAN, and CREDENCE trials presented at ASN Kidney Week.
Carla Nester spoke about two presentations at Kidney Week focused on potential therapies for C3 glomerulopathy.
Sagar Nigwekar discussed interim data from the SEAPORT 1 trial of INZ-701 for treatment of calciphylaxis.
Jesse Goodrich and Hailey Hampson spoke about their study of the connection between PFAS, the gut, and kidney function.
Guru Reddy discussed three posters presented by Unicycive Therapeutics at ASN Kidney Week 2024, on UNI-494 and OLC.
Jonathan Barratt discussed advances in IgA nephropathy treatment with Joel Topf at ASN Kidney Week 2024.
Susan Quaggin, winner of the 2024 John P. Peters Award, spoke with us about the award, her work, and ASN Kidney Week.
Melissa Little discussed kidney regeneration and her stem cell research with Joel Topf of Nephrology Times.
Mohamad Hussain spoke with us about a phase 3 trial of the acellular tissue engineered vessel in AV access for hemodialysis.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.